We had the opportunity to study one patient affected with CVID due to a de novo heterozygous non-sense mutation (p.Arg853*) in NFKB2 and demonstrated impaired NK cell cytotoxic activity despite normal NK cell counts and normal expression of different NK receptors (41). Here, NFKB2 is linked to common variable immunodeficiency.